INOGEN, INC. (NASDAQ:INGN) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
Results of Operations and Financial Condition.
INOGEN, INC. (NASDAQ:INGN) Files An 8-K Results of Operations and Financial Condition
On August 3, 2017, Inogen, Inc. issued a press release reporting its financial results for the second quarter ended June 30, 2017. A copy of the press release is furnished herewith as Exhibit99.1 to this Current Report on Form 8-K.
The information furnished in this Current Report under Item 2.02 and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
|
Item 2.02. |
Financial Statements and Exhibits. |
(d)Exhibits
|
Exhibit |
Description |
|
99.1 |
Press Release, dated August 3, 2017. |
Inogen Inc ExhibitEX-99.1 2 ingn-ex991_6.htm EX-99.1 ingn-ex991_6.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Inogen Announces Record Second Quarter 2017 Financial Results – Q2 2017 Sales Revenue up 27.3% Over the Same Period in 2016 – – Q2 2017 Net Income up 11.3% Over the Same Period in 2016 – – Increasing 2017 Guidance – Goleta,…To view the full exhibit click here
About INOGEN, INC. (NASDAQ:INGN)
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.
